Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Market Research Future | PRODUCT CODE: 1545628

Cover Image

PUBLISHER: Market Research Future | PRODUCT CODE: 1545628

Asia Pacific Lancet and Pen Needles Market Research Report Data by Type, Application (Insulin, Capillary Blood Sampling, Hormones, Glucose Like Peptide, Skin Testing, and Others), End Use, by Region Forecast to 2032

PUBLISHED:
PAGES: 1112 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2950
PDF & Excel (Multi User License)
USD 3950
PDF & Excel (Enterprise License)
USD 5250

Add to Cart

Asia Pacific Lancet and Pen Needles Market Research Report Data by Type (lancets and pen needles), Application (Insulin, Capillary Blood Sampling, Hormones, Glucose Like Peptide (GLP), Skin Testing, and Others), End Use (Hospitals & Clinics, Diagnostic Centers & Medical Institutions, Home Care & Home Diagnostics, Research & Academic Laboratories, and Others), by Region (China, India Japan, South Korea, Australia, and Rest of the Asia-Pacific) Forecast to 2032

Market Synopsis

The Asia Pacific Lancet and Pen Needles Market is projected to grow at a robust rate, with a compound annual growth rate of Lancets are single-use tools/devices used by healthcare providers for limited blood testing. Lancets are an essential component of programs in hospitals, clinics, research facilities, and doctor's offices that aim to prevent sharp injuries. One of the most utilized substitute tools for drawing blood is a lancet. Lancets and pen needles are becoming more and more popular around the world because of their many practical features, which provide them an advantage over more conventional vein puncture techniques. A hollow needle that fits into a plastic hub and fastens to injection pens makes up a pen needle. Injectable drugs are administered into the body using injection pens and pen needles.

The main factors propelling the growth of the Asia-Pacific lancet and pen needles market are the rising rates of diabetes in the region and the market players' strategic initiatives related to pen needles. However, it is anticipated that alternative medication delivery technologies may limit the growth of the Asia-Pacific market. However, it is projected that the Asia-Pacific region's aging population will generate profitable prospects for the industry.

Market Segmentation

Based on product type, the Asia-Pacific lancet and pen needles market has been divided into two segments: lancets and pen needles.

Based on application, the lancet and pen needle market has been divided into segments such as insulin, hormones, glucose-like peptide (GLP), capillary blood sample, skin testing, and others.

Based on the end user, the lancet and pen needle market is segmented into home care & diagnostics, medical facilities & diagnostic centers, hospitals & clinics, research & academic laboratories, and others.

The Asia-Pacific lancet and pen needle market has been divided into China and India based on country. Australia, South Korea, Japan, and the remaining Asia-Pacific countries. In 2022, China held the biggest market share. Nonetheless, throughout the course of the projection period, India is expected to develop at the greatest CAGR.

Principal Players

Novo Nordisk A/S, Terumo Corporation, B. Braun SE, Nipro Corporation, Abbott, and Cardinal Health are the major industry participants.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TECHNIQUE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING INCIDENCES OF DIABETES ACROSS THE ASIA-PACIFIC REGION
    • 4.2.2 STRATEGIC INITIATIVES ASSOCIATED WITH PEN NEEDLE IN BY MARKET PLAYERS
  • 4.3 RESTRAINTS
    • 4.3.1 ALTERNATIVE METHODS FOR DRUG DELIVERY
  • 4.4 OPPORTUNITY
    • 4.4.1 GROWING GERIATRIC POPULATION IN ASIA-PACIFIC REGION

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 IMPACT OF COVID-19 ON THE ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET

6 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 LANCET
    • 6.2.1 SAFETY LANCET
      • 6.2.1.1 PUSH BUTTON SAFETY LANCET
      • 6.2.1.2 PRESSURE ACTIVATED SAFETY LANCET
      • 6.2.1.3 SIDE BUTTON SAFETY LANCET
    • 6.2.2 REGULAR LANCET
  • 6.3 PEN NEEDLES
    • 6.3.1 STANDARD NEEDLES
    • 6.3.2 SAFETY NEEDLES

7 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 INSULIN DELIVERY
  • 7.3 CAPILLARY BLOOD SAMPLING
  • 7.4 HORMONE DELIVERY
  • 7.5 GLUCOSE LIKE PEPTIDE (GLP) DELIVERY
  • 7.6 SKIN TESTING
  • 7.7 OTHERS

8 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS & CLINICS
  • 8.3 DIAGNOSTIC CENTERS
  • 8.4 HOME CARE & HOME DIAGNOSTICS
  • 8.5 RESEARCH & ACADEMIC LABORATORIES

9 ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, BY COUNTRY

  • 9.1 OVERVIEW
  • 9.2 ASIA-PACIFIC
    • 9.2.1 CHINA
    • 9.2.2 INDIA
    • 9.2.3 JAPAN
    • 9.2.4 AUSTRALIA
    • 9.2.5 SOUTH KOREA
    • 9.2.6 REST OF ASIA-PACIFIC

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET SHARE ANALYSIS, 2022
  • 10.3 COMPETITOR DASHBOARD
  • 10.4 PUBLIC PLAYERS STOCK SUMMARY
  • 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

11 COMPANY PROFILES

  • 11.1 NOVO NORDISK A/S
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 TERUMO CORPORATION
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 PHOENIX HEALTHCARE SOLUTIONS, LLC
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 KEY STRATEGIES
  • 11.4 CARDINAL HEALTH
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 NANCHANG YILI MEDICAL INSTRUMENT CO., LTD
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 KEY STRATEGY
  • 11.6 ABBOTT
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 SWOT ANALYSIS
    • 11.6.6 KEY STRATEGIES
  • 11.7 JIANGSU HUIDA MEDICAL INSTRUMENTS CO., LTD
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 KEY STRATEGIES
  • 11.8 B. BRAUN SE
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 NIPRO CORPORATION
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 KEY STRATEGIES
  • 11.10 ADVACARE PHARMA
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES

12 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 NUMBER OF INDIVIDUALS WITH DIABETES, BY COUNTRY (2022)
  • TABLE 3 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 4 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR LANCET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 5 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 6 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR SAFETY LANCET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 7 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR SAFETY LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 8 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR PUSH BUTTON SAFETY LANCET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 9 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR PRESSURE ACTIVATED SAFETY LANCET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 10 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR SIDE BUTTON SAFETY LANCET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 11 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR REGULAR LANCET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 12 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR PEN NEEDLES, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 13 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR PEN NEEDLES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 14 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR STANDARD NEEDLES, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 15 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR SAFETY NEEDLES, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 16 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 17 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR INSULIN DELIVERY, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 18 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR CAPILLARY BLOOD SAMPLING, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 19 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR HORMONE DELIVERY, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 20 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR GLUCOSE LIKE PEPTIDE (GLP) DELIVERY, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 21 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR SKIN TESTING, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 22 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR OTHERS, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 23 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 24 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR HOSPITALS & CLINICS, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 25 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 26 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR HOME CARE & HOME DIAGNOSTICS, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 27 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, FOR RESEARCH & ACADEMIC LABORATORIES BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 28 ASIA-PACIFIC MARKET ANALYSIS: LANCET AND PEN NEEDLE MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 29 CHINA LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 30 CHINA LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 31 CHINA LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 32 CHINA LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 33 CHINA LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 34 CHINA LANCET AND PEN NEEDLE MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 35 INDIA LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 36 INDIA LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 37 INDIA LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 38 INDIA LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 39 INDIA LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 40 INDIA LANCET AND PEN NEEDLE MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 41 JAPAN LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 42 JAPAN LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 43 JAPAN LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 44 JAPAN LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 45 JAPAN LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 46 JAPAN LANCET AND PEN NEEDLE MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 47 AUSTRALIA LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 48 AUSTRALIA LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 49 AUSTRALIA LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 50 AUSTRALIA LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 51 AUSTRALIA LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 52 AUSTRALIA LANCET AND PEN NEEDLE MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 53 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 54 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 55 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 56 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 57 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 58 SOUTH KOREA LANCET AND PEN NEEDLE MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 59 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 60 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, FOR LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 61 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, FOR SAFETY LANCET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 62 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, FOR PEN NEEDLES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 63 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 64 REST OF ASIA-PACIFIC LANCET AND PEN NEEDLE MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 65 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 66 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 67 NOVO NORDISK A/S: PRODUCTS OFFERED
  • TABLE 68 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 69 PHOENIX HEALTHCARE SOLUTIONS, LLC: PRODCUTS OFFERED
  • TABLE 70 CARDINAL HEALTH: PRODUCTS OFFERED
  • TABLE 71 NANCHANG YILI MEDICAL INSTRUMENT CO., LTD: PRODUCTS OFFERED
  • TABLE 72 ABBOTT: PRODUCTS OFFERED
  • TABLE 73 JIANGSU HUIDA MEDICAL INSTRUMENTS CO., LTD: PRODUCTS OFFERED
  • TABLE 74 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 75 NIPRO CORPORATION: PRODUCTS OFFERED
  • TABLE 76 ADVACARE PHARMA: PRODCUTS OFFERED

LIST OF FIGURES

  • FIGURE 1 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET: STRUCTURE
  • FIGURE 2 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
  • FIGURE 5 NUMBER OF PEOPLE AGED 60 YEARS OR OVER IN ASIA-PACIFIC, BY SUBREGION, 2022, 2030 AND 2050
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET
  • FIGURE 7 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022 & 2032 (USD MILLION)
  • FIGURE 8 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET SHARE (%), BY TYPE, 2022
  • FIGURE 9 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION)
  • FIGURE 10 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET SHARE (%), BY APPLICATION, 2022
  • FIGURE 11 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET, BY END USER, 2022 & 2032 (USD MILLION)
  • FIGURE 12 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET SHARE (%), BY END USER, 2022
  • FIGURE 13 ASIA-PACIFIC MARKET ANALYSIS: LANCET AND PEN NEEDLE MARKET, 2019-2032 (USD MILLION)
  • FIGURE 14 ASIA-PACIFIC MARKET ANALYSIS: LANCET AND PEN NEEDLE MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 15 ASIA-PACIFIC MARKET ANALYSIS: LANCET AND PEN NEEDLE MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 16 ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET PLAYERS: COMPETITIVE ANALSIS, 2022
  • FIGURE 17 COMPETITOR DASHBOARD: ASIA-PACIFIC LANCET AND PEN NEEDLES MARKET
  • FIGURE 18 NOVO NORDISK A/S: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 19 NOVO NORDISK A/S: SWOT ANALYSIS
  • FIGURE 20 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 21 TERUMO CORPORATION: SWOT ANALYSIS
  • FIGURE 22 CARDINAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 23 CARDINAL HEALTH: SWOT ANALYSIS
  • FIGURE 24 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 25 ABBOTT: SWOT ANALYSIS
  • FIGURE 26 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 27 B. BRAUN SE: SWOT ANALYSIS
  • FIGURE 28 NIPRO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!